Literature DB >> 27268074

Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality?

Lydia Feinstein1, Christian E Douglas2, Rebecca C Stebbins3, Graham Pawelec4, Amanda M Simanek5, Allison E Aiello6.   

Abstract

The social patterning of cytomegalovirus (CMV) and its implication in aging suggest that the virus may partially contribute to socioeconomic disparities in mortality. We used Cox regression and inverse odds ratio weighting to quantify the proportion of the association between socioeconomic status (SES) and all-cause mortality that was attributable to mediation by CMV seropositivity. Data were from the National Health and Nutrition Examination Survey (NHANES) III (1988-1994), with mortality follow-up through December 2011. SES was assessed as household income (income-to-poverty ratio ≤1.30;>1.30 to≤1.85;>1.85 to≤3.50;>3.50) and education (<high school; high school; >high school). We found strong associations between low SES and increased mortality: hazard ratio (HR) 1.80; 95% confidence interval (CI): 1.57, 2.06 comparing the lowest versus highest income groups and HR 1.29; 95% CI: 1.13, 1.48 comparing <high school versus >high school education. 65% of individuals were CMV seropositive, accounting for 6-15% of the SES-mortality associations. Age modified the associations between SES, CMV, and mortality, with CMV more strongly associated with mortality in older individuals. Our findings suggest that cytomegalovirus may partially contribute to persistent socioeconomic disparities in mortality, particularly among older individuals.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aging; Cytomegalovirus; Mortality; NHANES III; Socioeconomic status

Mesh:

Year:  2016        PMID: 27268074      PMCID: PMC5018206          DOI: 10.1016/j.mad.2016.06.001

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  70 in total

Review 1.  Infiltration of the brain by pathogens causes Alzheimer's disease.

Authors:  R F Itzhaki; M A Wozniak; D M Appelt; B J Balin
Journal:  Neurobiol Aging       Date:  2004 May-Jun       Impact factor: 4.673

2.  Splines for trend analysis and continuous confounder control.

Authors:  Chanelle J Howe; Stephen R Cole; Daniel J Westreich; Sander Greenland; Sonia Napravnik; Joseph J Eron
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

3.  Socioeconomic gradients in immune response to latent infection.

Authors:  Jennifer Beam Dowd; Mary N Haan; Lynn Blythe; Kari Moore; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2007-09-14       Impact factor: 4.897

4.  Direct and indirect effects in a survival context.

Authors:  Theis Lange; Jørgen V Hansen
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

Review 5.  Oncomodulatory mechanisms of human cytomegalovirus in gliomas.

Authors:  Kaveh Barami
Journal:  J Clin Neurosci       Date:  2010-04-27       Impact factor: 1.961

6.  Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly.

Authors:  Sine Reker Hadrup; Jan Strindhall; Tania Køllgaard; Tina Seremet; Boo Johansson; Graham Pawelec; Per thor Straten; Anders Wikby
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

Review 7.  Immunosenenescence: role of cytomegalovirus.

Authors:  Graham Pawelec
Journal:  Exp Gerontol       Date:  2013-11-28       Impact factor: 4.032

8.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

9.  Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Authors:  Enrique F Schisterman; Stephen R Cole; Robert W Platt
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

10.  New advances in CMV and immunosenescence.

Authors:  Paolo Sansoni; Rosanna Vescovini; Francesco F Fagnoni; Arne Akbar; Ramon Arens; Yen-Ling Chiu; Luka Cičin-Šain; Julie Dechanet-Merville; Evelyna Derhovanessian; Sara Ferrando-Martinez; Claudio Franceschi; Daniela Frasca; Tamas Fulöp; David Furman; Effrossyni Gkrania-Klotsas; Felicia Goodrum; Beatrix Grubeck-Loebenstein; Mikko Hurme; Florian Kern; Daniele Lilleri; Miguel López-Botet; Andrea B Maier; Thomas Marandu; Arnaud Marchant; Catharina Matheï; Paul Moss; Aura Muntasell; Ester B M Remmerswaal; Natalie E Riddell; Kathrin Rothe; Delphine Sauce; Eui-Cheol Shin; Amanda M Simanek; Megan J Smithey; Cecilia Söderberg-Nauclér; Rafael Solana; Paul G Thomas; Rene van Lier; Graham Pawelec; Janko Nikolich-Zugich
Journal:  Exp Gerontol       Date:  2014-04-03       Impact factor: 4.032

View more
  13 in total

1.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

2.  Race/Ethnic and Educational Disparities in the Association Between Pathogen Burden and a Laboratory-Based Cumulative Deficits Index.

Authors:  Grace A Noppert; A E Aiello; A M O'Rand; H J Cohen
Journal:  J Racial Ethn Health Disparities       Date:  2019-10-22

Review 3.  'From immunosenescence to immune modulation': a re-appraisal of the role of cytomegalovirus as major regulator of human immune function.

Authors:  Paul Moss
Journal:  Med Microbiol Immunol       Date:  2019-05-03       Impact factor: 3.402

4.  Life Course Socioeconomic Disadvantage and the Aging Immune System: Findings From the Health and Retirement Study.

Authors:  Grace A Noppert; Rebecca C Stebbins; Jennifer B Dowd; Robert A Hummer; Allison E Aiello
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2021-06-14       Impact factor: 4.077

5.  The Association Between Cytomegalovirus and Disability by Race/Ethnicity and Sex: Results From the Health and Retirement Study.

Authors:  Kate A Duchowny; Grace A Noppert
Journal:  Am J Epidemiol       Date:  2021-11-02       Impact factor: 4.897

6.  Cytomegalovirus vaccines under clinical development.

Authors:  Mark R Schleiss
Journal:  J Virus Erad       Date:  2016-10-05

Review 7.  Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?

Authors:  James E Turner; Patricia C Brum
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

8.  High cytomegalovirus serology and subsequent COPD-related mortality: a longitudinal study.

Authors:  Raffaella Nenna; Jing Zhai; Samuel E Packard; Amber Spangenberg; Duane L Sherrill; Fernando D Martinez; Marilyn Halonen; Stefano Guerra
Journal:  ERJ Open Res       Date:  2020-04-27

9.  Persistent socioeconomic and racial and ethnic disparities in pathogen burden in the United States, 1999-2014.

Authors:  R C Stebbins; G A Noppert; A E Aiello; E Cordoba; J B Ward; L Feinstein
Journal:  Epidemiol Infect       Date:  2019-11-11       Impact factor: 2.451

10.  Correspondence Between Cytomegalovirus Immunoglobulin-G Levels Measured in Saliva and Serum.

Authors:  Jenna L Riis; Hedyeh Ahmadi; Olivia Silke; Steve W Granger; Crystal I Bryce; Douglas A Granger
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.